Endometrioid Adenocarcinoma

general

An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.

75

Centers

125

Active Trials

$839M

Cancer Funding

Specific Cancer Types(1)

NameCenters
Metastatic Endometrioid Adenocarcinoma17

Top Centers for Endometrioid Adenocarcinoma(75)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Clinical
High-Volume Research Center
72.9
2
NCI Comprehensive
Active Research Program
68.9
3
NCI Comprehensive
Active Research Program
68.9
468.9
5
NCI Comprehensive
Active Research Program
68.9
6
NCI Comprehensive
Active Research Program
68.9
7
NCI Comprehensive
Active Research Program
68.9
8
Active Research Program
68.9
9
NCI Clinical
Active Research Program
68.9
10
Active Research Program
68.9
11
NCI Comprehensive
Active Research Program
68.9
12
Active Research Program
68.9
13
Active Research Program
68.9
14
NCI Comprehensive
Active Research Program
55.9
15
NCI Comprehensive
Active Research Program
55.9
16
NCI Comprehensive
Active Research Program
55.9
17
NCI Comprehensive
Active Research Program
55.9
18
NCI Comprehensive
Active Research Program
55.9
19
NCI Comprehensive
Active Research Program
55.9
20
NCI Comprehensive
Active Research Program
55.9
21
NCI Comprehensive
Active Research Program
55.9
22
NCI Comprehensive
Active Research Program
55.9
23
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
55.9
24
NCI Comprehensive
Active Research Program
55.9
25
NCI Comprehensive
Active Research Program
55.9
26
NCI Comprehensive
Active Research Program
55.9
27
NCI Clinical
Active Research Program
55.9
28
NCI Comprehensive
Active Research Program
55.9
29
NCI Comprehensive
Active Research Program
55.9
30
NCI Comprehensive
Active Research Program
55.9
31
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
55.9
32
NCI Comprehensive
Active Research Program
55.9
33
NCI Comprehensive
Active Research Program
55.9
34
NCI Comprehensive
Active Research Program
55.9
35
NCI Comprehensive
Active Research Program
55.9
36
NCI Comprehensive
Active Research Program
55.9
37
NCI Clinical
Active Research Program
55.9
38
Active Research Program
55.9
3955.9
40
Active Research Program
55.9
41
NCI Basic_laboratory
Active Research Program
55.9
42
Active Research Program
55.9
43
Active Research Program
55.9
44
NCI Comprehensive
Active Research Program
39.0
45
NCI Comprehensive
Active Research Program
39.0
46
NCI Comprehensive
Active Research Program
39.0
47
NCI Comprehensive
Active Research Program
39.0
48
NCI Comprehensive
Active Research Program
39.0
49
NCI Comprehensive
Active Research Program
39.0
50
NCI Comprehensive
Active Research Program
39.0
51
NCI Comprehensive
Active Research Program
39.0
52
NCI Comprehensive
Active Research Program
39.0
53
Active Research Program
39.0
54
Active Research Program
39.0
55
NCI Clinical
Active Research Program
39.0
56
NCI Comprehensive
Active Research Program
39.0
57
Active Research Program
39.0
58
Active Research Program
39.0
59
Active Research Program
39.0
60
Active Research Program
39.0
61
Active Research Program
39.0
62
Active Research Program
39.0
63
Active Research Program
39.0
64
Active Research Program
39.0
65
Active Research Program
39.0
66
Active Research Program
39.0
67
Active Research Program
39.0
68
Active Research Program
39.0
69
NCI Comprehensive
29.7
70
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
29.7
71
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
29.7
72
BC CancerVancouver, BC
29.7
7329.7
74
75
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →